158 related articles for article (PubMed ID: 14692038)
1. Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.
Lüttges J; Stigge C; Pacena M; Klöppel G
Cancer; 2004 Jan; 100(1):173-82. PubMed ID: 14692038
[TBL] [Abstract][Full Text] [Related]
2. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
3. Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.
Perez EA; Gutierrez JC; Koniaris LG; Neville HL; Thompson WR; Sola JE
J Pediatr Surg; 2009 Jan; 44(1):197-203. PubMed ID: 19159743
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
James TA; Sheldon DG; Rajput A; Kuvshinoff BW; Javle MM; Nava HR; Smith JL; Gibbs JF
Cancer; 2004 Dec; 101(12):2722-6. PubMed ID: 15534880
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
Dancer J; Takei H; Ro JY; Lowery-Nordberg M
Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
[TBL] [Abstract][Full Text] [Related]
6. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
[TBL] [Abstract][Full Text] [Related]
7. Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.
Fitzgerald TL; Hickner ZJ; Schmitz M; Kort EJ
Pancreas; 2008 Aug; 37(2):134-8. PubMed ID: 18665072
[TBL] [Abstract][Full Text] [Related]
8. Family history of diabetes and pancreatic cancer.
Egawa N; Tu Y; Sanaka M; Kamisawa T
Pancreas; 2005 Jan; 30(1):15-9. PubMed ID: 15632694
[TBL] [Abstract][Full Text] [Related]
9. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma.
Del Chiaro M; Zerbi A; Falconi M; Bertacca L; Polese M; Sartori N; Boggi U; Casari G; Longoni BM; Salvia R; Caligo MA; Di Carlo V; Pederzoli P; Presciuttini S; Mosca F
Pancreatology; 2007; 7(5-6):459-69. PubMed ID: 17912010
[TBL] [Abstract][Full Text] [Related]
10. Intraductal tubulopapillary neoplasms of the pancreas distinct from pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Yamaguchi H; Shimizu M; Ban S; Koyama I; Hatori T; Fujita I; Yamamoto M; Kawamura S; Kobayashi M; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Ebihara Y; Koike N; Furukawa T
Am J Surg Pathol; 2009 Aug; 33(8):1164-72. PubMed ID: 19440145
[TBL] [Abstract][Full Text] [Related]
11. Cystic pancreatic endocrine tumor: a variant commonly confused with cystic adenocarcinoma.
Deshpande V; Lauwers GY
Cancer; 2007 Feb; 111(1):47-53. PubMed ID: 17173321
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological aspects of pancreatic cancer].
Egawa S; Sunamura M; Abe H; Motoi F; Fukuyama S; Matsuno S
Gan To Kagaku Ryoho; 2005 May; 32(5):605-11. PubMed ID: 15918558
[TBL] [Abstract][Full Text] [Related]
13. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry.
Carpelan-Holmström M; Nordling S; Pukkala E; Sankila R; Lüttges J; Klöppel G; Haglund C
Gut; 2005 Mar; 54(3):385-7. PubMed ID: 15710987
[TBL] [Abstract][Full Text] [Related]
14. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma.
Stoecklein NH; Luebke AM; Erbersdobler A; Knoefel WT; Schraut W; Verde PE; Stern F; Scheunemann P; Peiper M; Eisenberger CF; Izbicki JR; Klein CA; Hosch SB
J Clin Oncol; 2004 Dec; 22(23):4737-45. PubMed ID: 15570074
[TBL] [Abstract][Full Text] [Related]
15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
16. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms.
Choi MG; Kim SW; Han SS; Jang JY; Park YH
Arch Surg; 2006 Jan; 141(1):51-6; discussion 56. PubMed ID: 16415411
[TBL] [Abstract][Full Text] [Related]
17. Fine-needle aspiration cytology of mucinous tumors of the pancreas.
Recine M; Kaw M; Evans DB; Krishnamurthy S
Cancer; 2004 Apr; 102(2):92-9. PubMed ID: 15098253
[TBL] [Abstract][Full Text] [Related]
18. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Hiraoka N; Onozato K; Kosuge T; Hirohashi S
Clin Cancer Res; 2006 Sep; 12(18):5423-34. PubMed ID: 17000676
[TBL] [Abstract][Full Text] [Related]
20. Where and when does pancreatic carcinoma start?
Lüttges J; Hahn S; Klöppel G
Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
